These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
750 related items for PubMed ID: 33999797
21. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H, Sato K, Saito H. Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [Abstract] [Full Text] [Related]
22. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system. Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S. PLoS One; 2018 Jul; 13(9):e0203108. PubMed ID: 30222736 [Abstract] [Full Text] [Related]
23. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex. Brown-Elliott BA, Philley JV, Griffith DE, Thakkar F, Wallace RJ. Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065 [Abstract] [Full Text] [Related]
24. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients]. Kuwabara K, Tsuchiya T. Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685 [Abstract] [Full Text] [Related]
25. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. Hirama T, Shiono A, Egashira H, Kishi E, Hagiwara K, Nakamura H, Kanazawa M, Nagata M. J Clin Microbiol; 2016 Mar; 54(3):699-704. PubMed ID: 26739154 [Abstract] [Full Text] [Related]
26. Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens. Kim SY, Shin SH, Moon SM, Yang B, Kim H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Koh WJ. Diagn Microbiol Infect Dis; 2017 Jun; 88(2):125-137. PubMed ID: 28291631 [Abstract] [Full Text] [Related]
27. Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates. Lee SH, Park YK, Kim CK, Kim HJ. J Clin Lab Anal; 2011 Jun; 25(1):33-6. PubMed ID: 21254240 [Abstract] [Full Text] [Related]
28. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints. Schön T, Chryssanthou E. Int J Infect Dis; 2017 Feb; 55():122-124. PubMed ID: 28069470 [Abstract] [Full Text] [Related]
29. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S. J Infect Chemother; 2018 May; 24(5):353-357. PubMed ID: 29361415 [Abstract] [Full Text] [Related]
30. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin. Reisner BS, Woods GL, Popov VL. Int J Tuberc Lung Dis; 1997 Jun; 1(3):270-5. PubMed ID: 9432376 [Abstract] [Full Text] [Related]
31. Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs. Tomioka H, Sato K, Saito H, Yamada Y. Microbiol Immunol; 1989 Jun; 33(6):509-14. PubMed ID: 2770562 [Abstract] [Full Text] [Related]
32. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K. BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764 [Abstract] [Full Text] [Related]
33. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease. Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, Shin SJ, Kwon OJ. Chest; 2012 Dec 27; 142(6):1482-1488. PubMed ID: 22628488 [Abstract] [Full Text] [Related]
34. [Non-tuberculous mycobacteriosis. What has been coming out]. Kajiki A. Kekkaku; 2011 Feb 27; 86(2):113-25. PubMed ID: 21404655 [Abstract] [Full Text] [Related]
35. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Tomioka H, Sato K, Saito H. Kekkaku; 1993 Apr 27; 68(4):293-9. PubMed ID: 8497119 [Abstract] [Full Text] [Related]
36. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. Sirichoat A, Kaewprasert O, Hinwan Y, Faksri K. PLoS One; 2023 Apr 27; 18(11):e0294677. PubMed ID: 37992075 [Abstract] [Full Text] [Related]
37. Direct identification and discernment of Mycobacterium avium and Mycobacterium intracellulare using a real-time RNA isothermal amplification and detection method. Cui Z, Li Y, Cheng S, Yang H, Lu J, Zhu H, Hu Z. Tuberculosis (Edinb); 2015 Dec 27; 95(6):764-769. PubMed ID: 26316142 [Abstract] [Full Text] [Related]
38. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes. Aoki A, Jinno H, Ogawa K, Nakagawa T, Inagaki T, Wajima T, Okamoto Y, Uchiya KI. Microbiol Spectr; 2023 Feb 14; 11(1):e0432622. PubMed ID: 36622171 [Abstract] [Full Text] [Related]
39. Antimicrobial susceptibility testing and genotyping of Mycobacterium avium isolates of two tertiary tuberculosis designated hospital, China. Wei G, Huang M, Wang G, Huo F, Dong L, Li Y, Huang H. Infect Genet Evol; 2015 Dec 14; 36():141-146. PubMed ID: 26391006 [Abstract] [Full Text] [Related]
40. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Tomioka H, Saito H, Fujii K, Sato K, Hidaka T. Antimicrob Agents Chemother; 1993 Jan 14; 37(1):67-70. PubMed ID: 8431020 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]